Modern paradigms for prostate cancer detection and management

Author:

Williams Isabella SC1,McVey Aoife2,Perera Sachin1,O’Brien Jonathan S23,Kostos Louise2,Chen Kenneth24,Siva Shankar23,Azad Arun A23,Murphy Declan G25,Kasivisvanathan Veeru25,Lawrentschuk Nathan13,Frydenberg Mark67

Affiliation:

1. Royal Melbourne Hospital Melbourne VIC

2. Peter MacCallum Cancer Centre Melbourne VIC

3. University of Melbourne Melbourne VIC

4. Singapore General Hospital Singapore Singapore

5. University College London London United Kingdom

6. Monash University Melbourne VIC

7. Cabrini Institute, Cabrini Health Melbourne VIC

Publisher

Wiley

Subject

General Medicine

Reference92 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Australian Institute for Health and Welfare. Cancer in Australia 2021 [Cat. No. CAN 144].https://www.aihw.gov.au/getmedia/0ea708eb‐dd6e‐4499‐9080‐1cc7b5990e64/aihw‐can‐144.pdf.aspx?inline=true(viewed Apr 2022).

3. Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis

4. Analysis of Magnetic Resonance Imaging–directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis

5. European Association of Urology. EAU guidelines 2022 edition [website].https://uroweb.org/guidelines(viewed Apr 2022).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3